Biotech

All Articles

Lilly- supported weight-loss biotech reports IPO

.After elevating $170 million back in February, metabolic disease-focused BioAge Labs has submitted ...

Aelis' marijuana usage drug flunks period 2b, steering Indivior to reassess $100M alternative

.Aelis Farma's chances of getting an easy, beneficial choice on a $one hundred million option repaym...

ProKidney standstills stage 3 trial certainly not required for tissue therapy permission

.ProKidney has actually quit some of a set of period 3 tests for its own cell therapy for renal illn...

Vaxcyte climbs on 'magnificent' 31-valent PCV succeed against Pfizer

.Vaxcyte unveiled what professionals called "remarkable" stage 1/2 information for its own 31-valent...

Recursion's brain ailment trial presents little evidence of effectiveness

.Recursion has actually discovered through a very early examination of its tech-enabled strategy to ...

Acepodia, Pfizer click all together for chemistry-based cell treatment

.Phone it an instance of great chemical make up: Acepodia, a biotech based on Nobel Champion science...

Praxis epilepsy drug minimizes seizures in stage 2 litigation

.Practice Preciseness Medicines has scored an additional midphase win in epilepsy this year, with it...

Three directors surrender as Dyne posts combined information for DMD applicant

.After getting away a clinical grip many years back, Dyne Therapeutics has revealed brand-new period...

Arrowhead fires off period 3 information in uncommon metabolic ailment in advance of market clash with Ionis

.Arrowhead Pharmaceuticals has actually shown its give in front of a possible face-off with Ionis, r...

Pfizer, Valneva reveal lyme illness shot successful for 2nd enhancer

.Pfizer as well as Valneva might possess regarding 2 additional years to wait prior to they produce ...